NO982282L - Synergistisk immunsuppresjonspreparat inneholdende en 2,2'-bi-1H-pyrrolforbindelse - Google Patents

Synergistisk immunsuppresjonspreparat inneholdende en 2,2'-bi-1H-pyrrolforbindelse

Info

Publication number
NO982282L
NO982282L NO982282A NO982282A NO982282L NO 982282 L NO982282 L NO 982282L NO 982282 A NO982282 A NO 982282A NO 982282 A NO982282 A NO 982282A NO 982282 L NO982282 L NO 982282L
Authority
NO
Norway
Prior art keywords
alkyl
phenyl
hydrogen
alkenyl
pyrrole compound
Prior art date
Application number
NO982282A
Other languages
English (en)
Other versions
NO982282D0 (no
Inventor
Mario Ferrari
Paola Gnocchi
Maria Chiara Fornasiero
Francesco Colotta
Alessio Roberto D
Anna Maria Isetta
Original Assignee
Pharmacia & Upjohn Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia & Upjohn Spa filed Critical Pharmacia & Upjohn Spa
Publication of NO982282D0 publication Critical patent/NO982282D0/no
Publication of NO982282L publication Critical patent/NO982282L/no

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4245Oxadiazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/04Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A61K38/13Cyclosporins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/08Solutions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841Filling excipients; Inactive ingredients
    • A61K9/485Inorganic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841Filling excipients; Inactive ingredients
    • A61K9/4858Organic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/06Immunosuppressants, e.g. drugs for graft rejection

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Transplantation (AREA)
  • Inorganic Chemistry (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Produkt inneholdende: (a) et immunundertrykkende middel (A) og (b) minst en immunundertrkkende 2,2:-bi-lH-pyrrolforbindelse (B) som har formel (I): hvor R, er hydrogen, fenyl, C,-C20 alkyl eller C2-C20 alkenyl, hvor alkyl- og alkenyl- gruppene er usubstituert eller substituert med 1-3 substituenter, som er like eller for- skjellige, valgt uavhengig fra halogen, C,-C6 alkoksy, hydroksy, aryl og aryloksy; R2 er hydrogen, CrC6 alkyl, cyano, karboksy eller (C,-C6 alkoksy)karbonyl; R3 er halogen, hydroksy eller Cj-C,, alkoksy usubstituert eller substituert med fenyl; R« er hydrogen, C,-C6 alkyl eller fenyl; hver av R5 og R^, som er like eller forskjellige, er uavhengig hydrogen, C2-C20 alkanoyl, C3-C20 alkenoyl, fenyl, C,-C20 alkyl eller C2-C20 alkenyl; eMer to av R4, R5 og R,, danner sammen en C4-CU polymetylenkjede, som er usubstituert eller substituert med en CrC|2 alkyl-, med en C2-C12 alkenyl- eller med en C,-C12 alkylidengruppe; eller et farmasøytisk akseptabelt salt derav; som et kombinert preprat for samtidig, separat eller sekvensiell bruk i immunundertrykkelsesterapi, hvor preparatet har en potensiert immunundertrykkende aktivitet i forhold til produkter inne- holdende enten det immunundertrykkende midlet (A) eller den immunundertrykkende 2,2'-bi-l H-pyrrolforbindelsen (B).
NO982282A 1996-09-20 1998-05-19 Synergistisk immunsuppresjonspreparat inneholdende en 2,2'-bi-1H-pyrrolforbindelse NO982282L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9619706.6A GB9619706D0 (en) 1996-09-20 1996-09-20 Synergistic immunosuppressant composition containing a 2,2'-bi-1H-pyrrole comp und
PCT/EP1997/004884 WO1998011894A1 (en) 1996-09-20 1997-09-02 Synergistic immunosuppressant composition containing a 2,2'-bi-1h-pyrrole compound

Publications (2)

Publication Number Publication Date
NO982282D0 NO982282D0 (no) 1998-05-19
NO982282L true NO982282L (no) 1998-07-20

Family

ID=10800283

Family Applications (1)

Application Number Title Priority Date Filing Date
NO982282A NO982282L (no) 1996-09-20 1998-05-19 Synergistisk immunsuppresjonspreparat inneholdende en 2,2'-bi-1H-pyrrolforbindelse

Country Status (20)

Country Link
US (1) US6291509B1 (no)
EP (1) EP0866701B1 (no)
JP (1) JP2000501118A (no)
KR (1) KR19990067692A (no)
AR (1) AR009086A1 (no)
AT (1) ATE211909T1 (no)
AU (1) AU4383197A (no)
BR (1) BR9706790A (no)
CA (1) CA2238043A1 (no)
DE (1) DE69709618T2 (no)
EA (1) EA000925B1 (no)
ES (1) ES2174288T3 (no)
GB (1) GB9619706D0 (no)
HU (1) HUP9901988A3 (no)
MX (1) MX9803920A (no)
NO (1) NO982282L (no)
NZ (1) NZ330655A (no)
PL (1) PL326759A1 (no)
WO (1) WO1998011894A1 (no)
ZA (1) ZA978187B (no)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0867701A1 (en) 1997-03-28 1998-09-30 Interuniversitair Microelektronica Centrum Vzw Method of fabrication of an infrared radiation detector and more particularly an infrared sensitive bolometer
ATE474590T1 (de) 1999-05-10 2010-08-15 Paolo Brenner Kombination von immunsuppressiven substanzen zur behandlung oder vorbeugung von transplantat abstossungen
US6407244B1 (en) 2000-01-26 2002-06-18 Gemin X Biotechnologies Inc. Pyrrole-type compounds, compositions, and methods for treating cancer or viral diseases
US20040014987A1 (en) 2000-01-26 2004-01-22 Gemin X Biotechnologies Inc. Pyrrole-Type compounds, compositions, and methods for treating cancer or viral diseases
MXPA04000402A (es) 2001-07-18 2004-03-18 Gemin X Biotechnologies Inc Compuestos de tipo pirrol, composiciones que los contienen, y metodos que los emplean para el tratamiento de cancer y enfermedades virales y para causar inmunosupresion.
KR100674222B1 (ko) * 2005-07-11 2007-01-24 한국생명공학연구원 세라시아 마르세센스 b-1231 kctc 0386bp로부터분리한 프로디지오신을 유효성분으로 포함한 급성이식편대숙주병의 예방 및 치료용 조성물
CN103387529B (zh) * 2013-07-30 2016-03-30 中国农业科学院烟草研究所 抗tmv的三吡咯环类化合物及其制备方法和用途
WO2017177216A1 (en) * 2016-04-08 2017-10-12 Institute For Cancer Research D/B/A The Research Institute Of Fox Chase Cancer Center Prodigiosin analogs

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9326284D0 (en) * 1993-12-23 1994-02-23 Erba Carlo Spa Pyrrolydenemethyl-derivatives and process for their preparation

Also Published As

Publication number Publication date
EA000925B1 (ru) 2000-06-26
HUP9901988A2 (hu) 1999-10-28
JP2000501118A (ja) 2000-02-02
DE69709618D1 (de) 2002-02-21
ES2174288T3 (es) 2002-11-01
EA199800464A1 (ru) 1999-02-25
PL326759A1 (en) 1998-10-26
HUP9901988A3 (en) 2000-09-28
MX9803920A (es) 1998-09-30
BR9706790A (pt) 1999-06-01
AR009086A1 (es) 2000-03-08
CA2238043A1 (en) 1998-03-26
US6291509B1 (en) 2001-09-18
GB9619706D0 (en) 1996-11-06
NZ330655A (en) 2000-01-28
ZA978187B (en) 1998-03-03
DE69709618T2 (de) 2002-08-29
AU4383197A (en) 1998-04-14
NO982282D0 (no) 1998-05-19
EP0866701B1 (en) 2002-01-16
WO1998011894A1 (en) 1998-03-26
ATE211909T1 (de) 2002-02-15
EP0866701A1 (en) 1998-09-30
KR19990067692A (ko) 1999-08-25

Similar Documents

Publication Publication Date Title
EP1070710A3 (en) Dithiolan derivatives, their preparation and their therapeutic effect
HUP9903377A2 (hu) Makrociklusos bisz(indolil)-maleinimid-származék, eljárás előállítására, alkalmazása és a vegyületet tartalmazó gyógyszerkészítmények
RU95108759A (ru) Фармацевтические соединения
CA2316921A1 (en) Aryl fused azapolycyclic compounds
NZ520071A (en) 4-aminopiperidine derivatives and their use as medicine
SV1999000141A (es) Derivados de quinolin-2-ona alquinilsustituidos utiles como agentes anticancerosos ref. pc10411abcz/bb
AR007828A1 (es) Compuestos derivados de piridilpirrol, procedimiento de preparacion y composiciones farmaceuticas conteniendo los mismos
WO2000007542A3 (es) Empleo de derivados de aril(o heteroaril)azolilcarbinoles en la elaboracion de un medicamento para el tratamiento de los trastornos mediados por un exceso de substancia p
BG102820A (en) Substituted tetracyclic tetrahydrofurane derivatives
CA2360754A1 (en) Use of pyridazino[4,5-b]indole-1-acetamide derivatives for preparing medicines for treating diseases related to the dysfunction of peripheral benzodiazepin receptors
NO982282L (no) Synergistisk immunsuppresjonspreparat inneholdende en 2,2'-bi-1H-pyrrolforbindelse
NO985622D0 (no) Utvalgte derivater av K-252A
EP0765865A4 (en) 2-ACYLAMINOPROPANOL COMPOUND AND MEDICINAL COMPOSITION
ES8400438A1 (es) Procedimiento para preparar derivados de (3h)-imidazo(5,1-d)-1,2,3,5-tetrazin-4-ona.
NO904668L (no) Fremgangsmaate for fremstilling av 5,6,7-trinor-4,8-inter-m-fenylen-pgi2-derivater.
NO974749L (no) Fremgangsmåte for fremstilling av 2,2'-bipyrrolyl-pyrrometen (prodigiosiner) -derivater
CA2316388A1 (en) Tetrahydrobenzindole derivative
DE69508421D1 (de) SPIRO[HETEROZYCLISCHE-IMIDAZO[1,2-a]INDENO[1,2-e]PYRAZIN]-4'-ONE, IHRE HERSTELLUNG UND DIESE ENTHALTENDE ARZNEIMITTEL
HUP9904514A2 (hu) 5H-Pirrolo[2,1-c][1,4]-benzodiazepin-3-karboxamid-származékok, eljárás előállításukra, alkalmazásuk és az azokat tartalmazó gyógyszerkészítmények
IL121432A (en) Pyrrolo [3,2-C]azepine-4-one derivatives and pyrrolo [3,4-C]azepine-4-one derivatives their preparation and pharmaceutical compositions containing them
MY117086A (en) 3''-aziridino-anthracycline derivatives.
HUP0002291A2 (hu) Pirrolo-tiazin- és pirrolo-tiazepin-származékok, eljárás előállításukra és ilyen vegyületeket tartalmazó gyógyszerkészítmények
MY103561A (en) Pestidal method using 2-phenylimidazole derivatives
CA2168514A1 (en) Isocarbacyclin derivatives
AU526978B2 (en) Tetracyclic indole derivatives

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application